Similar to Ozempic, Adderall may also be prescribed off-label for weight loss as decreased appetite and weight loss are potential side effects of the medication
The first FDA-approved tirzepatide medication is Mounjaro, originally indicated for type 2 diabetes
Notably, in April/May 2025, they have partnered with Eli Lilly to offer Zepbound and Novo Nordisk to offer Wegovy (see our notes for updates)
This improved tolerance makes it suitable for longer-term use
Typically injected under the skin, the drug lowers appetite, slows digestion and increases insulin levels, causing blood sugar levels to drop
Regional company and only available in four states, Maine, Massachusetts, and New Hampshire